
AOD9604
Research Peptide | Lyophilized Powder | Batch Tested
For laboratory research use only. Not for human or animal consumption. Insulated shipping · Styrofoam box available.
Product Overview
AOD9604 is a modified fragment corresponding to the C-terminal region (residues 176-191) of human growth hormone, isolated specifically to study lipid metabolism. The fragment retains the fat-metabolizing signal of growth hormone while lacking the IGF-1-driven growth and glucose effects of the intact hormone.
| Test | Result | Status |
|---|---|---|
| Purity | 98.5% | Passed ✓ |
| Test | Result | Status |
|---|---|---|
| Purity | 98.3% | Passed ✓ |
| Test | Result | Status |
|---|---|---|
| Purity | 99.1% | Passed ✓ |
Research Information
AOD9604 is used to investigate lipolysis and fat-oxidation pathways in adipocyte and animal models, testing the hypothesis that growth hormone's effect on fat can be separated from its growth-promoting activity. Studies examine its influence on stored triglyceride breakdown and its lack of effect on IGF-1 and blood glucose. Supplied strictly for in-vitro and laboratory research use only — not for human or animal consumption.
AOD9604 Research & Studies
What is AOD9604?
AOD9604 is a synthetic peptide fragment corresponding to the C-terminal region of human growth hormone, specifically residues 176-191 with an N-terminal tyrosine modification. It is employed in laboratory research to examine lipid metabolism signals that can be isolated from the broader activities of intact growth hormone. The compound is designed for investigation of fat-related pathways without the IGF-1-associated growth or glucose effects of the parent molecule. It is supplied strictly for in-vitro and laboratory research use only.
Mechanism of Action
In experimental systems AOD9604 is studied for its capacity to engage pathways linked to lipolysis and fatty-acid oxidation within adipocytes. Research explores how the fragment may promote breakdown of stored triglycerides through signals distinct from those of full-length growth hormone. Investigations focus on the absence of measurable stimulation of IGF-1 production or alterations in blood glucose parameters. These features allow researchers to probe selective metabolic mechanisms in controlled model systems.
Primary Areas of Research
AOD9604 is used to investigate lipolysis and fat-oxidation pathways in adipocyte cultures and animal models. Studies test the hypothesis that growth hormone’s effect on fat can be separated from its growth-promoting activity. Work centers on influence over stored triglyceride breakdown and the lack of concurrent effects on IGF-1 or glucose homeostasis. All investigations remain confined to non-clinical laboratory settings for mechanistic insight.
Key Research Findings
Laboratory models have been employed to assess AOD9604’s influence on triglyceride mobilization in isolated adipocytes. Observations indicate retention of lipolytic signaling alongside no detectable impact on IGF-1 levels or blood glucose in the systems examined. These findings support the concept that the C-terminal fragment can convey fat-metabolizing activity independently of anabolic or hyperglycemic effects. Data are derived exclusively from preclinical experimental preparations.
Research Handling & Considerations
AOD9604 is intended solely for research use and must be handled under standard laboratory peptide protocols. Appropriate cold storage and careful reconstitution are required to preserve structural integrity for experimental work. The material is restricted to in-vitro assays and approved animal model studies and is not for human or animal consumption. Researchers must follow institutional guidelines for documentation and ethical use of research peptides.
Frequently Asked Questions
AOD9604 is studied for lipolysis and fat-oxidation pathways in adipocyte and animal models, testing separation of growth hormone’s fat-metabolizing signals from growth-promoting activity.
Explore Other High-Purity Peptides

Semaglutide

Tirzepatide

Retatrutide
